Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
life sciences
6
×
national blog main
clinical trials
boston blog main
boston top stories
san francisco blog main
san francisco top stories
startups
deals
medical device
national top stories
new york blog main
new york top stories
biotech ipos
boston
cancer
cancer drugs
covid-19
drug delivery
fda
hepatitis b
investing
ipo
pfizer
renaissance capital
san diego blog main
san diego top stories
san francisco
the column group
10x genomics
480 biomedical
abbvie
aligos therapeutics
allergan aesthetics
alnylam
alzheimer's disease
amgen
arena pharmaceuticals
arsenal medical
What
way
6
×
ipo
medicines
biotech
debut
drugs
markets
new
public
raises
research
treat
week
acquisitions
advance
biggest
bio
biologics
biotechs
boost
build
buy
cancer
cancer’s
central
ceo
cns
companies
company
company’s
considered
daniel
deliver
developing
disease
diseases
disorder
drug
dtx
dyne’s
Language
unset
6
×
Current search:
way
×
unset
×
" life sciences "
×
@xconomy.com
3 years ago
Praxis Precision Medicines Leads Way as Three More Biotechs Prep IPOs
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M